,0
symbol,AXLA
price,5.15
beta,0.0
volAvg,156098
mktCap,187701536
lastDiv,0.0
range,2.25-7.73
changes,-0.18
companyName,Axcella Health Inc
currency,USD
cik,0001633070
isin,US05454B1052
cusip,05454B105
exchange,NasdaqGM
exchangeShortName,NASDAQ
industry,Biotechnology
website,http://www.axcellahealth.com/
description,"Axcella Health, Inc. is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. The company is headquartered in Cambridge, Massachusetts and currently employs 64 full-time employees. The firm focuses on research and development of multifactorial interventions to support health and address dysregulated metabolism across a spectrum of consumers. The company designs and develops endogenous metabolic modulators. Its AXA Development Platform produces a pipeline of AXA candidates with programs in liver, muscle and blood. The Companyâ€™s wholly owned pipeline comprises five programs focused on the metabolic functions of the liver, muscle and blood. The company offers AXA1665 for use in treating Hepatic Encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways."
ceo,Mr. William Hinshaw
sector,Healthcare
country,US
fullTimeEmployees,69
phone,16178680949
address,840 Memorial Dr
city,Cambridge
state,MASSACHUSETTS
zip,02139
dcfDiff,
dcf,10.0099
image,https://financialmodelingprep.com/image-stock/AXLA.png
ipoDate,2019-05-09
defaultImage,False
